InsidersTradesSigma
Follow the 엠젠솔루션 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 엠젠솔루션 has recorded 7 public disclosures. Market capitalisation: €23.9bn. The latest transaction was filed on 10 July 2026 (Sale). Among the most active insiders: 최은경. Every trade is free.
7
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
4 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,613 of 29,057 companies
8.5
score / 100
Value8
Quality9
FCF yld-16%
Earn yld-55%
EV/EBITDA·
ROE-48%
Gross mgn15%
Net mgn-57%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations7 total
2,320,740 sharesKRXDART:20260701000658
7 of 7 declarations
Acerca de 엠젠솔루션
엠젠솔루션 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.